ZBNA
BMRN icon

Zions Bancorporation, National Association’s BioMarin Pharmaceuticals BMRN Stock Holding History

Zions Bancorporation, National Association’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Buy
547
+172
+46% +$9.42K ﹤0.01% 656
2026
Q1 		$21.2K Buy
375
+364
+3,309% +$21.2K ﹤0.01% 721
2025
Q4 		$654 Buy
+11
New +$599 ﹤0.01% 1172

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM

Zions Bancorporation, National Association's BMRN Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its BioMarin Pharmaceuticals (BMRN) stake by 46% in Q2 2026, buying an estimated $9.42K and bringing the position to 547 shares worth $31.3K. The position accounts for ﹤0.01% of the portfolio, ranked #656.

Zions Bancorporation, National Association first reported a position in BMRN in Q4 2025 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Zions Bancorporation, National Association held 547 shares of BioMarin Pharmaceuticals worth $31.3K as of Q2 2026.
  • Zions Bancorporation, National Association bought 172 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $9.42K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #656 holding.
  • Zions Bancorporation, National Association first reported a position in BioMarin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.